endurant and endurant ii stent graft system
Medtronic Vascular
FDA Clearance Information
The Endurant and Endurant II stent graft systems received FDA premarket approval (PMA) on July 8, 2014. Manufactured by Medtronic Vascular, they are classified as Class III medical devices.
What It Is
Clinical Applications
Evidence Summary
Reported Outcomes
Safety Profile
Evidence Limitations
Linked Studies (15)
Endurant Stent Graft for Treatment of Abdominal Aortic Aneurysm Inside and Outside of the Instructions for Use for the Proximal Neck: A 14-Year, Single-Center Experience.
Journal of clinical medicine
View Source →Treatment of Aortoiliac Aneurysms: Compatibility of the E-liac Stent Graft (Artivion®, Iliac Branch Device) with Endurant II or IIs (Medtronic®, EVAR).
Cardiovascular and interventional radiology
RCT|prospective|retrospective|case Series|other View Source →A Retrospective Evaluation of Intra-Prosthetic Thrombus Formation After Endovascular Aortic Repair in Cook Zenith Alpha and Medtronic Endurant II Patients.
European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery
Retrospective View Source →Long-term Outcomes of the Endurant and Excluder Stent Grafts for Endovascular Aneurysm Repair in a Japanese Cohort.
Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists
RCT|prospective|retrospective|case Series|other View Source →Outcomes of Endurant II Stent Graft According to Anatomic Severity Grade Score.
Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists
RCT|prospective|retrospective|case Series|other View Source →Primary Endovascular Treatment of Late-Onset Type 3 Endovascular Aortic Repair Rupture Using The Endurant II Stent Graft and Rapid Response Protocol.
Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir
RCT|prospective|retrospective|case Series|other View Source →Type II Endoleak After Endovascular Aortic Aneurysm Repair Using the Endurant Stent Graft System for Abdominal Aortic Aneurysm with Occluded Inferior Mesenteric Artery.
Cardiovascular and interventional radiology
RCT|prospective|retrospective|case Series|other View Source →Preliminary experience with the Endurant II short form stent-graft system.
The Journal of cardiovascular surgery
Other View Source →Use of Endurant Stent-Graft Aortic Extensions for the Treatment of Focal Aortic Pathology.
Annals of vascular surgery
Other View Source →Cinical outcomes of Endurant II stent-graft for infrarenal aortic aneurysm repair: comparison of on-label versus off-label use.
Diagnostic and interventional radiology (Ankara, Turkey)
RCT|prospective|retrospective|case Series|other View Source →Predictive factors for limb occlusions after endovascular aneurysm repair.
Journal of vascular surgery
RCT|prospective|retrospective|case Series|other View Source →Anatomic suitability for endovascular repair of abdominal aortic aneurysms and possible benefits of low profile delivery systems.
Vascular
RCT|prospective|retrospective|case Series|other View Source →Endurant stent-graft system: preliminary report on an innovative treatment for challenging abdominal aortic aneurysm.
The Journal of cardiovascular surgery
RCT|prospective|retrospective|case Series|other View Source →Endurant™ Stent Graft System in the Treatment of Infra-renal Abdominal Aortic Aneurysms (ENDURANT France)
View Source →Frequently Asked Questions
What are the clinical indications for Endurant and Endurant II stent graft systems?
The devices are indicated for the repair of abdominal aortic aneurysms, particularly in patients unsuitable for open surgical repair.
What outcomes have been reported in clinical studies?
Studies report effective aneurysm exclusion, with outcomes such as reduced limb graft occlusion and intra-prosthetic thrombus formation.
What complications have been reported?
Safety data indicate complications such as limb graft occlusion and intra-prosthetic thrombus formation, necessitating careful patient monitoring.